Beta Bionics (BBNX) Shares Outstanding (Weighted Average) (2023 - 2026)

Beta Bionics has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $44.4 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $44.4 million, up 44.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.4 million (up 44.67% YoY), and the FY2024 annual result was $6.4 million, up 20.01% from the prior year.
• Shares Outstanding (Weighted Average) came in at $44.4 million for Q1 2026 at Beta Bionics, up from $43.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $44.4 million in Q1 2026 to a low of $5.3 million in Q4 2023.
• The 4-year median for Shares Outstanding (Weighted Average) is $6.7 million (2024), against an average of $20.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 20.01% in 2024 and jumped 555.12% in 2025, its largest moves.
• Beta Bionics' Shares Outstanding (Weighted Average) stood at $5.3 million in 2023, then advanced by 20.01% to $6.4 million in 2024, then soared by 585.52% to $43.6 million in 2025, then gained by 1.84% to $44.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $44.4 million (Q1 2026), $43.6 million (Q3 2025), and $37.1 million (Q2 2025), per Business Quant data.